Andrea Tan
Stock Analyst at Goldman Sachs
(0.33)
# 2594
Out of 5,354 analysts
52
Total ratings
35.71%
Success rate
-9.97%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeut... | Maintains: Buy | 16 8 | 1.84 | 334.78% | 7 | May 12, 2025 | |
TARS Tarsus Pharmaceutica... | Maintains: Neutral | 46 51 | 42.69 | 19.47% | 4 | May 5, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 39 27 | 6.95 | 288.49% | 6 | Mar 25, 2025 | |
INSM Insmed | Maintains: Strong Buy | 74 102 | 73.77 | 38.27% | 9 | Jul 10, 2024 | |
SGMT Sagimet Biosciences | Maintains: Neutral | 23 6 | 4.05 | 48.15% | 5 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 31 | 16.73 | 85.3% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.74 | 170.27% | 3 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Sell | 2 | 3.98 | -49.75% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 17 | n/a | n/a | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 132.07 | 21.15% | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 2.42 | 891.74% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 10 4 | 1.43 | 179.72% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 178 375 | 279.2 | 34.31% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 13 | 5.29 | 145.75% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | n/a | n/a | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | 0.23 | 1639.13% | 2 | May 24, 2022 |